Brand leadership & market authority: Align your market position with enterprise value
Build the kind of brand investors believe in. Let’s start aligning your market position with your enterprise value.
AI-powered growth operations: Where data intelligence meets human precision
At Legacy DNA, we integrate artificial intelligence as an acceleration tool, not a replacement for expertise.
How Axium grew 10x and became Kroger's entry into specialty pharmacy
A tenfold increase in revenue, an acquisition by the fifth largest pharmacy operator in the country, and a management team the acquirer chose to keep.
How BioPlus became a business two buyers wanted to own
Inside the transformation that doubled revenue, redefined a category, and led to multiple premium acquisitions.
From pain to power: How Hinge Health built a category buyers could not ignore
Inside the journey from personal conviction to market dominance and what every healthtech CEO can learn about Exit Readiness.
Healthcare market expansion: Scale confidently. Grow enterprise value.
Expanding market share in healthcare is one of the fastest ways to increase enterprise value. It’s also one of the hardest.
The silent risk buyers look for in founder-led healthcare companies
Founder-led healthcare companies often win early because of the founder’s credibility, relationships, and clinical expertise. But when buyers evaluate the business for an acquisition, they are testing whether the growth engine works without the founder in the room. When that answer is unclear, risk appears.
What makes a healthtech legend?
Here are three traits that instantly separate healthtech legends from the rest and command premium multiples.
How a late entrant took 23% of the category and became the brand the merger kept
How a late entrant took 23% of the category from the incumbent, and why the merged company kept the challenger's name.
Five hard truths exit buyers won’t tell you
Most CEOs lose millions because they don’t see what buyers really value.
Strategic growth consulting: Turning traction into scalable, enterprise-level growth
We partner with growth-stage and PE-backed leaders to realign strategy, narrative, and execution, so every commercial lever drives measurable enterprise value.
The #1 reason healthtech companies fail to scale
High burn isn’t momentum; it’s fragility. See how efficient growth drives higher multiples.
Positioning & valuation strategy: Turn market noise into negotiating power
Innovation doesn’t equal enterprise value. You can have a proven product, strong revenue, and loyal customers, yet still be undervalued if buyers can’t quickly grasp your value.
Fast vs. durable growth: Which increases your valuation more?
Does fast growth always increase your valuation? Learn how buyers assess growth, red flags that reduce multiples, and how to strengthen exit readiness.
From late entrant to category leader: How ParcelShield unlocked scale and acquisition with AI
Inside the transformation that clarified ParcelShield’s AI-driven value, captured 23% market share, and positioned the company for private equity acquisition.